Broadfin Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Broadfin Capital’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-323,188	Closed	-$4.8M	–	99
2015 Q3	$4.8M	Sell	323,188 -25,016	-7%	-$587K	0.27%	68
2015 Q2	$7.62M	Hold	348,204	–	–	0.41%	56
2015 Q1	$7.84M	Sell	348,204 -65,000	-16%	-$1.51M	0.61%	46
2014 Q4	$8.34M	Buy	413,204 +200,000	+94%	+$3.62M	0.73%	38
2014 Q3	$3.89M	Sell	213,204 -50,000	-19%	-$724K	0.41%	52
2014 Q2	$3.55M	Hold	263,204	–	–	0.35%	58
2014 Q1	$4.33M	Buy	+263,204	New	+$4.55M	0.42%	57

Other funds holding FLXN

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital's FLXN Position: Q4 2015 in Review

Broadfin Capital sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2015, closing a stake of 323,188 shares — an estimated $4.8M sold.

Broadfin Capital first reported a position in FLXN in Q1 2014 and held it in 7 quarters. The position peaked at $8.34M in Q4 2014. 64 funds tracked by Wall St. Rank hold FLXN as of Q4 2015.

Broadfin Capital reported no remaining Flexion Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Broadfin Capital sold 323,188 Flexion Therapeutics, Inc. shares in Q4 2015, an estimated $4.8M.
Broadfin Capital first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Broadfin Capital's Flexion Therapeutics, Inc. position peaked at $8.34M in Q4 2014.
64 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2015.

Based on Broadfin Capital's 13F filing for Q4 2015, filed 16 Feb 2016.